Abstract

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2018 - Volume 22, Number 5

Page(s): 409

Download in electronic PDF format for $75
  • Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Page 1

Abstract

A formulation for preparing Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • fluoxetine
  • topical preparation
  • transdermal absorption
  • anxiety
  • selective serotonin reuptake inhibitor
  • SSRI

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • MENTAL HEALTH
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2018
Pg. 409
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Nov/Dec 2006
Pg. 418
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Author(s): Fields Shannon W
May/Jun 2017
Pg. 242-246
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2014
Pg. 253-255
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Author(s): Peacock Gina F, Sauvageot Jurgita
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jan/Feb 2007
Pg. 73
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2012
Pg. 248-252
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Author(s): Lehman Paul A, Raney Sam G
May/Jun 2009
Pg. 244
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 180-183
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 242-246
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
Jan/Feb 2012
Pg. 62-63
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Author(s): Bramwell Bethany L, Williams LaVonn A
May/Jun 2009
Pg. 245
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 200-203
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Author(s): Wynn Tom, Goetsch Daniel
Jul/Aug 2021
Pg. 322
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Author(s): Allen Loyd V Jr
Nov/Dec 2009
Pg. 569-571
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Author(s): Arnold John J, Asbill Scott
Mar/Apr 2019
Pg. 146
Acetaminophen 50% Pluronic Lecithin Organogel Gel
Author(s): Allen Loyd V Jr